➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 9,592,293

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,592,293
Title:Interleukin-13 binding proteins
Abstract: The present invention encompasses IL-13 binding proteins. Specifically, the invention relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Preferred antibodies have high affinity for hIL-13 and neutralize hIL-13 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-13 and for inhibiting hIL-13 activity, e.g., in a human subject suffering from a disorder in which hIL-13 activity is detrimental.
Inventor(s): Wu; Chengbin (Shanghai, CN), Dixon; Richard W. (Jefferson, MA), Belk; Jonathan P. (Sterling, MA), Argiriadi; Maria A. (Wayland, MA), Ying; Hua (Holden, MA), Cuff; Carolyn A. (Grafton, MA), Melim; Terry L. (Derry, NH), Kumar; Shankar (Pleasanton, CA), Hinton; Paul R. (Sunnyvale, CA), Chen; Yan (Fremont, CA)
Assignee: AbbVie Inc. (North Chicago, IL)
Application Number:14/101,145
Patent Claims:see list of patent claims

Details for Patent 9,592,293

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Start Trial AbbVie Inc. (North Chicago, IL) 2026-09-08 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Start Trial AbbVie Inc. (North Chicago, IL) 2026-09-08 RX Orphan search
Jubilant Hollisterstier Llc POSITIVE SKIN TEST CONTROL - HISTAMINE histamine INJECTION 103891 1 1995-06-15   Start Trial AbbVie Inc. (North Chicago, IL) 2026-09-08 search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20   Start Trial AbbVie Inc. (North Chicago, IL) 2026-09-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.